Literature DB >> 9510654

Epiblepharon of the lower eyelid: classification and association with astigmatism.

S I Khwarg1, Y J Lee.   

Abstract

To determine a classification system for epiblepharon of the lower eyelid and to evaluate a possible correlation between lower lid epiblepharon and astigmatism. Three morphologic characteristics (skin fold, cilia touching the cornea and corneal erosion) were observed by slit-lamp biomicroscopic examination and Polaroid pictures in 186 eyes of 102 patients with epiblepharon of the lower lid. In 112 eyes, cycloplegic refractions performed. A classification system reflecting the severity of epiblepharon was then sought, and the incidences and type of astigmatism were evaluated. Epiblepharon of the lower lid could be classified according to the height of skin fold, the area of cornea touched by cilia and the area of corneal erosion. There was significant agreement between these three classifications. The incidence of astigmatism of 0.5D or more was 54%; most was 'with-the-rule', regardless of a patient's age. In addition to the representative nature of other characteristics, skin fold height can be easily measured without the need for slit-lamp examination in children and is closely related with the amount of skin which should be excised during surgery to correct epiblepharon. A classification system using skin fold height may therefore be the most appropriate method. In addition, there may be a correlation between lower lid epiblepharon and astigmatism.

Entities:  

Mesh:

Year:  1997        PMID: 9510654     DOI: 10.3341/kjo.1997.11.2.111

Source DB:  PubMed          Journal:  Korean J Ophthalmol        ISSN: 1011-8942


  10 in total

1.  Surgical correction for lower lid epiblepharon in Asians.

Authors:  K I Woo; K Yi; Y D Kim
Journal:  Br J Ophthalmol       Date:  2000-12       Impact factor: 4.638

2.  Gene expression profiles of pro-inflammatory mediators in the conjunctiva of patients with epiblepharon.

Authors:  Bo Ram Kim; Yuri Seo; Hyun Jung Lee; So-Hyang Chung; Jin Sook Yoon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-02-05       Impact factor: 3.117

3.  Reporting outcomes of hyaluronic gel filler as a treatment for epiblepharon.

Authors:  John C Bladen; Raman Malhotra
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-10-22       Impact factor: 3.117

4.  Modified Epiblepharon Repair Preserving Orbicularis Oculi Muscle.

Authors:  Hyun Chul Youn; Seunghwan Lee; Ju-Hyang Lee
Journal:  J Ophthalmol       Date:  2022-07-11       Impact factor: 1.974

5.  Variations in the degree of epiblepharon with changes in position and induction of general anesthesia.

Authors:  Soolienah Rhiu; Jin Sook Yoon; Su Yan Zhao; Sang Yeul Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-11-01       Impact factor: 3.117

6.  The clinical characteristics and surgical outcomes of epiblepharon in korean children: a 9-year experience.

Authors:  Jong Soo Kim; Sang Wook Jin; Mun Chong Hur; Yoon Hyung Kwon; Won Yeol Ryu; Woo Jin Jeong; Hee Bae Ahn
Journal:  J Ophthalmol       Date:  2014-09-14       Impact factor: 1.909

7.  Relationship between lower eyelid epiblepharon and epicanthus in Korean children.

Authors:  Dong Hoon Shin; Kyung In Woo; Yoon-Duck Kim
Journal:  PLoS One       Date:  2017-11-21       Impact factor: 3.240

8.  Surgical Treatment of Epiblepharon Effectively Alleviates Keratopathy but Not Astigmatism: A Case-Control Study Utilizing Vector Analysis in East Asian Children.

Authors:  Shang-Te Ma; Yao-Lin Liu; Ching-Ju Hsieh; Yo-Shen Chen; Tzu-Hsun Tsai
Journal:  J Ophthalmol       Date:  2020-12-05       Impact factor: 1.909

9.  The prevalence of lower eyelid epiblepharon and its association with refractive errors in Chinese preschool children: a cross-sectional study.

Authors:  Deyi Zhuo; Si Chen; Xiaofang Ren; Bingsong Wang; Linbo Liu; Lin Xiao
Journal:  BMC Ophthalmol       Date:  2021-01-04       Impact factor: 2.209

10.  High-frequency radio wave electrocautery in modified Hotz operations for epiblepharon correction.

Authors:  Hyunkyu Lee; Jimin Youn; Sehyun Baek
Journal:  BMC Ophthalmol       Date:  2021-12-10       Impact factor: 2.209

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.